Home
NICE Guidance
NICE Advice
Evidence summaries

Attention deficit hyperactivity disorder in children and young people: lisdexamfetamine dimesylate

Evidence summary [ESNM19] Published: 07 May 2013

Advice

This evidence summary has been updated and replaced by NICE guideline NG87.